XOMIVI
"XOMIVI" is a word mark owned by Amgen Inc., filed at the USPTO on September 25, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since October 27, 2026
- Filed
- September 25, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50130174
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns XOMIVI
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Amgen Inc.
AMGN · Thousand Oaks, United States
Representative
Elsa D. Lemoine
What the mark covers
The products and services XOMIVI is filed for, grouped by Nice class.
Pharmaceutical and biological preparations for the prevention and treatment of obesity, cancer, osteoporosis, and inflammatory, autoimmune, cardiovascular, and blood diseases and disorders; Pharmaceutical and biological preparations for the prevention and treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiometabolic, genitourinary, oncological, hepatological, ophthalmic, otolaryngological, respiratory, neurological, nephrological, hematological, hormonal, dermatological, and immune system-related diseases and disorders; Pharmaceutical preparations
What has happened so far
Steps recorded by the USPTO, newest first.
- Assigned to examiner
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About XOMIVI
Who owns the trademark "XOMIVI"?
The USPTO trademark "XOMIVI" (application 50130174) is owned by Amgen Inc.
What is the status of "XOMIVI"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull XOMIVI and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a0ddd7-d344-72cf-8975-a14fa356b0d2
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a0ddd7-d344-72cf-8975-a14fa356b0d2",
"object": "trademark",
"mark_text": "XOMIVI",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50130174",
"filing_date": "2026-09-25",
"nice_classes": [
5
],
"owners": [
{
"name": "Amgen Inc.",
"entity_id": "ent_019eb6fb-7ab7-71bf-a46d-b0ba9848c4af"
}
]
}